Mankind Pharma
NSEI:MANKIND
Rp 2.005,80
Rp0,00 (0,00%)
2.005,80 Rp
Rp0,00 (0,00%)
End-of-day quote: 04/01/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp49,08
Earnings Per Share
Rp304,70
Revenue Per Share
0,00%
Gross Margin %
Rp828,05 B
Market Cap
Rp55,26 B
Long-Term Debt
Earnings Per Share
Rp49,08
Revenue Per Share
Rp304,70
Gross Margin %
0,00%
Market Cap
Rp828,05 B
Long-Term Debt
Rp55,26 B

Financials

Year Year 2025 2024 2023 2022
EPS Earnings Per Share Rp49,20 Rp47,68 Rp32,00 Rp35,78
Earnings Earnings Rp20,30B Rp19,10B Rp12,82B Rp14,33B
RPS Revenue Per Share Rp295,88 Rp304,70 Rp218,40 Rp0,00
Revenue Revenue Rp122,07B Rp122,07B Rp87,49B Rp0,00M
OCF Operating Cash Flow Rp24,13B Rp24,13B Rp18,13B Rp0,00M
FCF Free Cash Flow Rp19,05B Rp18,37B Rp10,24B Rp0,00M
OM Operating Margin 0,00% 0,00% 22,92% 0,00%
GM % Gross Margin % 0,00% 0,00% 69,66% 0,00%
FCFS Free Cash Flow Per Share Rp0,00 Rp0,00 Rp44,19 Rp0,00
LT Debt Long-Term Debt Rp55,26B Rp55,26B N/A N/A
Sha. Stocks 412,58M 400,64M 400,61M 400,59M
×